1[15]Rodriguez Barbero A, Obreo J, Yuste L, et al. Transforming growth factor-betal induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts[J]. FEBS Lett, 2002,513(2-3):282-288.
2[16]Chin BY, Mohsenin A, Li SX, et al. Stimulation of pro-alpha(1)(Ⅰ) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway[J]. Am J Physiol Renal Physiol, 2001,280(3) :F495-F504.
3[17]Wang L, Ma R, Flavell RA, et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-betal in murine mesangial cells[J]. J Biol Chem, 2002,277(49) :47257-47262.
4[18]Furukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofi broblasts[J]. Hepatology, 2003,38(4) :879-889.
5[19]Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J].Science, 2002,298(5600) :1911-1912.
6[1]Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases[J].Nat Rev Drug Discov, 2003,2(9):717-726.
7[2]Hunter T. Signaling-2000 and beyond[J]. Cell, 2000,100(1):113-127.
8[3]Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells[J]. Pharmacol Ther, 2001,91(1):1-34.
9[4]Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold[J]. Nat Rev Drug Discov, 2003,2(7) :554-565.
10[5]Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway[J]. Crit Care Med,2000,28(4 Suppl) :N67-N77.